Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: July 26, 2021

Here's some of HealthDay's top stories for Monday, July 26: Fauci pushes plan to help prevent future pandemics. America's leading infectious disease expert...

Iterum Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Oral Sulopenem

DUBLIN, Ireland and CHICAGO, July 26, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage...

Medical Groups Call for Mandatory COVID-19 Vaccination for Health Care Workers

MONDAY, July 26, 2021 -- All health care workers should be required to be vaccinated against COVID-19, dozens of major U.S. medical groups said in a joint...

​Survey Shows U.S. Parents Split on COVID-19 Vaccination for Children Under 12

MONDAY, July 26, 2021 -- As a new school year approaches, U.S. parents are nearly evenly split on whether they will vaccinate their young children when a...

Most Unvaccinated Americans Want to Stay That Way: Poll

MONDAY, July 26, 2021 -- Eight in 10 American adults who have not received a COVID-19 vaccine say they are unlikely to get one, according to the results of a...

Fauci Pushes Ambitious Plan to Guard Against Future Pandemics

MONDAY, July 26, 2021 -- In an effort to avoid another pandemic in the coming years, Anthony Fauci, M.D., director of the U.S. National Institute of Allergy...

U.S. to Stick With International Travel Restrictions

MONDAY, July 26, 2021 -- The rapid spread of the highly contagious delta variant around the world means that the United States will continue with COVID-19...

U.S. to Stick With International Travel Restrictions

MONDAY, July 26, 2021 -- The rapid spread of the highly contagious Delta variant around the world means that the United States will continue with COVID-19...

Worry, Depression, Burnout: Survey Finds College Students Stressed as Fall Term Nears

MONDAY, July 26, 2021 -- Like many of her peers, Ohio State University engineering student Mary Trabue spent much of the pandemic taking classes online. And...

Major Medical Groups Call for Mandatory COVID Vaccination for Health Workers

MONDAY, July 26, 2021 -- All health care workers should be required to be vaccinated against COVID-19, dozens of major U.S. medical groups said in a joint...

Worried About Delta-Linked 'Breakthrough' Infections? Experts Explain the Risks

MONDAY, July 26, 2021 -- Even if they're fully vaccinated against COVID-19, certain people may need to take extra precautions to prevent "breakthrough"...

FDA Accepts Braeburn’s New Drug Application Resubmission for Brixadi (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder

Plymouth Meeting, Pa. – June 26, 2021 – Braeburn announces that the New Drug Application (NDA) for Brixadi (buprenorphine) extended-release weekly...

Dalvance (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

NORTH CHICAGO, Ill., July 23, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Dalvance&reg...

FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

KENILWORTH & WOODCLIFF, N.J.--(BUSINESS WIRE) July 22, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai Inc. today...

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

BOSTON, July 20, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today...

FDA Approves Octapharma’s Octagam 10% for Adult Dermatomyositis

PARAMUS, N.J.--(BUSINESS WIRE) July 20, 2021 --The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% [Immune...

Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

FREMONT, Calif. and WALTHAM, Mass., July 19, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery...

FDA Approves Fexinidazole as the First All-Oral Treatment for Sleeping Sickness

July 19, 2021 -- The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei...

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant (diazepam) Buccal Film

WARREN, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing...

Status on FDA Advisory Committee Vote on Roxadustat in Anemia of Chronic Kidney Disease

16 July 2021 -- The Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted 13 to 1 that the...

New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopia, a Common and Progressive Eye Condition

NORTH CHICAGO, Ill., July 25, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced new data, including the full results from the...

Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)

WILMINGTON, Del.--(BUSINESS WIRE) July 23, 2021 -- Incyte Corporation (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has issued...

Vaxzevria is Highly Effective After One Dose Against Severe Disease or Hospitalisation Caused by Beta and Delta Variants of Concern

23 July 2021 Real-world data from Canada showed 82% and 87% effectiveness after one dose against hospitalisation or death caused by Beta/Gamma and Delta...

Anthos Therapeutics' Novel Factor XI Inhibitor Abelacimab Significantly Outperforms Standard of Care Enoxaparin in Prospective Phase 2 Efficacy Research Published in NEJM

CAMBRIDGE, Mass., July 19, 2021 /PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and...

Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain

BOSTON--(BUSINESS WIRE)--Jul. 19, 2021-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has begun a Phase 2 proof-of-concept (POC)...

Browse by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.